Scott O'Brien

Scott O'Brien currently serves as the Chief Commercial Officer (Fractional) at Astek Diagnostics, working on innovative technology for rapid urine-based UTI detection. As the Founder and Principal Consultant of Scott O Consulting, Scott provides strategic advice on corporate strategy, market access, and scientific evidence generation, particularly in clinical diagnostics. Scott is also a Board Member at LEX Diagnostics, which is focused on advancing point-of-care molecular diagnostics. Previously, Scott held the role of Chief Commercial Officer at Specific Diagnostics, where leadership contributed to the company's acquisition by bioMerieux, and served as Senior Vice President of Global Marketing & International Sales at GenMark Diagnostics, aiding in its acquisition by Roche. Scott's extensive experience spans several key positions at Illumina, Agilent Technologies, and Stratagene, consistently emphasizing product marketing, commercial strategy, and business development. Scott holds a Bachelor of Science degree in Microbiology from the University of Wisconsin-Madison.